Revolution Medicines Inc Warrant
RVMDW
24 hedge funds and large institutions have $1.71M invested in Revolution Medicines Inc Warrant in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
64% more capital invested
Capital invested by funds: $1.04M → $1.71M (+$669K)
1.72% more ownership
Funds ownership: 2.83% → 4.56% (+1.7%)
4% less funds holding
Funds holding: 25 → 24 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$767K |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$94.4K |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$39.9K |
| 4 |
D.E. Shaw & Co
New York
|
+$31.8K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
+$2.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.31K |
| 2 |
Walleye Capital
New York
|
-$863 |
| 3 |
CA
CoreCap Advisors
Southfield,
Michigan
|
-$14 |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$2 | -14 | Closed |
|
RVMDW Hedge Fund Activity: Q4 2024 in Review
24 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q4 2024, worth a combined $1.71M — up 64% from $1.04M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RVMDW and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was LMR Partners, opening a new position worth an estimated $767K. The largest seller was Citadel Advisors, exiting entirely with an estimated $3.31K sold.
- 24 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q4 2024, down from 25 in Q3 2024.
- Funds reported $1.71M of Revolution Medicines Inc Warrant stock for Q4 2024, up 64% quarter-over-quarter.
- 3 funds opened new Revolution Medicines Inc Warrant positions in Q4 2024 and 4 closed out, a net change of -1 holder.
- The largest Revolution Medicines Inc Warrant buyer in Q4 2024 was LMR Partners, an estimated $767K added.
- The largest Revolution Medicines Inc Warrant seller in Q4 2024 was Citadel Advisors, an estimated $3.31K sold.
Based on aggregated 13F filings for Q4 2024.